Nventa Annual Report 2005

New team. New focus. New pathway. New company.

View the annual report online, or

Download a PDF file of the Annual Report

Page 1 - Nventa is developing innovative therapeutics for the
treatment of viral infections and cancer, with a focus on diseases caused by the human papillomavirus (HPV). More...

Page 2 - The Company is Nventa. The therapeutic need is significant.
The potential to improve lives is vast. The target is HPV. More...

Page 3 - Promising technology. Continued optimism. Steadfast commitment. More...

Page 4 - Nventa management team More...

Page 5 - Why focus on HPV? An estimated 80 percent of sexually
active men and women are infected by genital human papillomavirus
(HPV) at some point in their lives.
Stronger Intellectual Property Portfolio More...

Page 6 - CoVal™ Fusions - Mechanism of Action. We are developing HspE7 as a drug for HPV -related conditions. One of our proprietary CoVal™ fusion proteins, HspE7, is made by using recombinant DNA technology to covalently fuse a Heat Shock Protein (Hsp) to an HPV E7 viral protein to form one CoVal™ therapeutic protein. More...

Page 7 - Milestones and Conclusions. All of this past year’s accomplishments have helped create a solid foundation to develop our portfolio of fusion-product candidates. Importantly, we believe our new strategy has already been validated externally by our ability to attract new, highly qualified individuals to our management team and Board of Directors, by the positive outcomes received around our intellectual property, and by the continued and dedicated support of our shareholder base. More...

Page 8 - 3 out of 4 Americans will acquire an HPV infection during their lifetime. More...

Page 9 - Corporate information More...

Page 10 - Corporate profile: Nventa is developing innovative therapeutics for the treatment of viral infections and cancer, with a focus on diseases caused by the human papillomavirus (HPV ).

Vision statement: Nventa is guided by a vision of making an immediate and significant difference in people’s lives by using novel approaches to create new and better treatments for an array of high-impact diseases. By pursuing this vision, we bring value to the healthcare community at large. More...